Cost-effectiveness of sodium zirconium cyclosilicate for advanced chronic kidney patients in Singapore.

Junxing Chay Jason Chon Jun Choo Eric Andrew Finkelstein

Published in: Nephrology (Carlton, Vic.) (2024)

This study establishes the cost-effectiveness of SZC as a treatment for HK, highlighting its potential to mitigate the risk of hyperkalaemia and optimise RAASi therapy. These findings emphasise the value of integrating SZC into the Singapore health system for improved patient outcomes and resource allocation.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
patient reported outcomes